Topamax Information
What's inside Topamax
Topamax Active Ingredients: topiramate, details.| Topamax Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Topamax 25 mg | tablet | oral | 1.0 each | OTC |
| Topamax 100 mg | tablet | oral | 1.0 each | OTC |
| Topamax 200 mg | tablet | oral | 1.0 each | OTC |
| Topamax 50 mg | tablet | oral | 1.0 each | OTC |
Recent Topamax Side Effects
Posted by iuridaen 15 days ago
I have been on 50 mg topiramate for a while now. It is part of a 5 drug mix used to address bipolar, anxiety and adult residu...
Posted by msdickso 15 days ago
I've only been on topamax for about a month and a half and already I'm feeling some interesting side effects. In the first we...
Posted by mjd 18 days ago
I have been on Topamax for about two years for migraines, and was very pleased that after the first month or two, most of the...
Topamax in the News
Study Finds IONSYS™, A New Needle-Free System For Management Of ... - Medical News Today (press release)
... CONCERTA® (ADHD), EPREX® (anaemia), SPORANOX® (fungal infections), VELCADE® (multiple myeloma), PARIET® (gastroenterology), TOPAMAX® (epilepsy), ...
Mon Mar 10 03:09:06 -0400 2008
Study finds IONSYS (TM), a New Needle-Free System for Management ... - PR Newswire UK (press release)
... SPORANOX(R) (fungal infections), VELCADE(R) (multiple myeloma), PARIET(R) (gastroenterology), TOPAMAX(R) (epilepsy), REMINYL(R) (Alzheimer's disease), ...
Tue Mar 04 01:06:57 -0500 2008
Benefiting From 2008's Generic Drugs - Motley Fool
Other blockbusters losing their patent protection in 2008 include Johnson & Johnson's (NYSE: JNJ) Topamax, which Barr Labs and Mylan (NYSE: MYL) are set to ...
Thu Feb 28 14:45:19 -0500 2008
Topamax Chemical Information
topiramate - A sulfamate-substituted monosaccharide with anticonvulsant property. Although the mechanism of action has not been fully elucidated, topiramate antagonizes kainate/AMPA subtype of the glutamate receptors, which are ligand-activated cation channels that mediate the fast component of excitatory postsynaptic currents in neurons of the central nervous system. This antagonistic action results in stabilizing hyper-excited neural membranes, inhibiting repetitive neuronal firing, and decreasing propagation of synaptic impulses, thereby impedes seizure occurrences. In addition, this agent augments gamma-aminobenzoic acid (GABA) activity and thereby attenuating GABAnergic inhibitory transmission.
Topamax RSS Feed
